21 CFR 862.1335
§ 862.1335 Glucagon test system.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 862.1335, § 862.1335 Glucagon test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89107
- Permanent ID
ys:prov:89107@1- SHA-256
b77297a33c87d68560ef00c1de5dccebbe5a46c37a9df455c336fd7278d1aca5
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. A glucagon test system is a device intended to measure the pancreatic hormone glucagon in plasma and serum. Glucagon measurements are used in the diagnosis and treatment of patients with various disorders of carbohydrate metabolism, including diabetes mellitus, hypoglycemia, and hyperglycemia.
(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.